NGALDS Trademark

Trademark Overview


On Monday, October 28, 2019, a trademark application was filed for NGALDS with the United States Patent and Trademark Office. The USPTO has given the NGALDS trademark a serial number of 79280943. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 7, 2021. This trademark is owned by BioPorto Diagnostics A/S. The NGALDS trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemicals used in industry and science; stem cells for research and scientific purposes; biochemical, namely, monoclonal antibodies for in vitro diagnostic scientific or industrial research; cells for scientific and research use, namely, DNA and RNA preparations for scientific and industrial purposes; proteins for use within science, namely, protein in raw material form for scientific research, protein assays for scientific research; diagnostic kits consisting primarily of monoclonal stem cells, antibodies and proteins for scientific research, in vitro diagnostic tests and disease testing; chemical reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; diagnostic test materials, namely, comprising diagnostic reagents, for scientific purposes, not for medical or veterinary purposes; assays for research purposes

Pharmaceutical and veterinary preparations for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; biological materials, namely, stem cells for medical and veterinary purposes; biological preparations for medical and veterinary purposes, specifically, for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; diagnostic kits and drug testing kits consisting primarily of stem cells, antibodies and proteins for medical and veterinary purposes for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; reagents for medical diagnosis and/or analysis; clinical medical reagents; diagnostic preparations for medical purposes; diagnostic test materials, namely, comprising diagnostic agents, preparations and substances for medical use; diagnostic kits comprising primarily diagnostic agents, preparations and substances for medical use; biological ...
ngalds

General Information


Serial Number79280943
Word MarkNGALDS
Filing DateMonday, October 28, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 7, 2021
Registration Number6358230
Registration DateTuesday, May 25, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 9, 2021

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemicals used in industry and science; stem cells for research and scientific purposes; biochemical, namely, monoclonal antibodies for in vitro diagnostic scientific or industrial research; cells for scientific and research use, namely, DNA and RNA preparations for scientific and industrial purposes; proteins for use within science, namely, protein in raw material form for scientific research, protein assays for scientific research; diagnostic kits consisting primarily of monoclonal stem cells, antibodies and proteins for scientific research, in vitro diagnostic tests and disease testing; chemical reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; diagnostic test materials, namely, comprising diagnostic reagents, for scientific purposes, not for medical or veterinary purposes; assays for research purposes
Goods and ServicesPharmaceutical and veterinary preparations for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; biological materials, namely, stem cells for medical and veterinary purposes; biological preparations for medical and veterinary purposes, specifically, for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; diagnostic kits and drug testing kits consisting primarily of stem cells, antibodies and proteins for medical and veterinary purposes for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; reagents for medical diagnosis and/or analysis; clinical medical reagents; diagnostic preparations for medical purposes; diagnostic test materials, namely, comprising diagnostic agents, preparations and substances for medical use; diagnostic kits comprising primarily diagnostic agents, preparations and substances for medical use; biological materials, namely, monoclonal antibodies for use in medical research, namely, in vitro diagnostic tests and disease testing
Pseudo MarkNGAL DS

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, June 27, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, June 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioPorto Diagnostics A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK-2900 Hellerup
DK

Party NameBioPorto Diagnostics A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK-2900 Hellerup
DK

Party NameBioPorto Diagnostics A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK-2900 Hellerup
DK

Trademark Events


Event DateEvent Description
Friday, July 23, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, July 23, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, July 17, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, July 17, 2021DEATH OF INTERNATIONAL REGISTRATION
Monday, July 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 25, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 9, 2021PUBLISHED FOR OPPOSITION
Sunday, March 7, 2021NOTIFICATION PROCESSED BY IB
Wednesday, February 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 7, 2021ASSIGNED TO LIE
Monday, September 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 18, 2020REFUSAL PROCESSED BY IB
Wednesday, April 1, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 1, 2020REFUSAL PROCESSED BY MPU
Saturday, March 21, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, March 18, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 17, 2020NON-FINAL ACTION WRITTEN
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Tuesday, March 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 12, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB